Medicines Australia yesterday issued a statement expressing concerns about a Financial Review report which it says brings into question the safety and ethics of clinical trials.
The AFR report describes the RIAT (Restoring Invisible and Abandoned Trials) initiative of the British Medical Journal which re-analyses clinical trial data.
MA said without the support of innovative medicine companies many trials would not go ahead meaning more effective medicines would be unavailable.The above article was sent to subscribers in Pharmacy Daily's issue from 18 Sep 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 18 Sep 15
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.